More about

Inflammation

News
February 17, 2024
8 min read
Save

Why the cardiovascular community needs to take a closer look at inflammation

Why the cardiovascular community needs to take a closer look at inflammation

Heart disease continues to be the leading cause of death and disability in the U.S. and worldwide. Atherosclerotic CVD, which is caused by plaque buildup in arterial walls, contributes to multiple life-threatening conditions.

News
February 10, 2024
1 min read
Save

Regular checks, gentle products recommended for aging skin

Regular checks, gentle products recommended for aging skin

MIAMI BEACH, Fla. — Xerosis can be a significant issue for patients as they age and dermatology practioners should both be aware and remain vigilant with whole body checks in older patients according to a poster presentation here.

News
February 09, 2024
4 min read
Save

AAAAI annual meeting to spotlight links between immune, other systems

AAAAI annual meeting to spotlight links between immune, other systems

Jonathan A. Bernstein, MD, president of the American Academy of Allergy, Asthma & Immunology, is very excited about the group’s Annual Meeting, scheduled for Feb. 23-26 in Washington, D.C.

News
February 09, 2024
2 min read
Save

JAK inhibitors have ‘untapped potential’ in treatment of inflammatory skin diseases

JAK inhibitors have ‘untapped potential’ in treatment of inflammatory skin diseases

MIAMI BEACH, Fla. — Janus kinase inhibitors have a unique mechanism of action, giving them the potential to push the boundaries of efficacy in the treatment of inflammatory skin diseases, according to a speaker at South Beach Symposium.

News
February 06, 2024
1 min read
Save

Silo Pharma announces roster of drugs in development for mental health, chronic pain

Silo Pharma announces roster of drugs in development for mental health, chronic pain

Silo Pharma will advance a portfolio of four drugs in its 2024 clinical pipeline, targeting conditions related to mental health, chronic pain and neurology.

News
February 01, 2024
1 min read
Save

Dry eye symptoms, ocular pain intensity associated with sleep disturbances

Dry eye symptoms, ocular pain intensity associated with sleep disturbances

Symptoms of dry eye disease were more closely related to sleep disturbances than exam findings, although inflammation and meibum quality were linked to subjective sleep quality, according to a study in BMJ Open Ophthalmology.

News
January 30, 2024
2 min read
Save

Aldosterone inhibitor BI 690517 reduced albuminuria when combined with SGLT2 inhibitor

Aldosterone inhibitor BI 690517 reduced albuminuria when combined with SGLT2 inhibitor

An experimental drug that inhibits aldosterone production reduced albuminuria in patients with chronic kidney disease, according to phase 2 study results published in The Lancet.

News
January 29, 2024
4 min read
Save

Multivariable blood test identifies aggressive prostate cancer more accurately than PSA

Multivariable blood test identifies aggressive prostate cancer more accurately than PSA

The Stockholm3 multivariable blood test demonstrated superior specificity of prostate cancer detection across a diverse population compared with PSA screening, according to findings presented at ASCO Genitourinary Cancers Symposium.

News
January 25, 2024
1 min read
Save

First patient dosed in study of dual inflammasome inhibitor for diabetic macular edema

First patient dosed in study of dual inflammasome inhibitor for diabetic macular edema

Inflammasome Therapeutics announced that the first patient has been dosed in its phase 1 study of K8, a novel dual inflammasome inhibitor for treatment of diabetic macular edema.

News
January 19, 2024
1 min read
Save

Eyenovia reacquires rights to MicroPine ophthalmic atropine spray in US, Canada

Eyenovia reacquires rights to MicroPine ophthalmic atropine spray in US, Canada

Eyenovia has announced the reacquisition of development and commercialization rights to MicroPine, an investigational 8 µL ophthalmic atropine spray being evaluated for pediatric progressive myopia.

View more